Pharmaceutical News

RSS

New bio-photonic device aims to take drug hypersensitivity detection into new era

Over 2.5 million people in Europe and more than 5.4 million Americans suffer from hypersensitivity to Beta Lactam Antibiotics (BLCs), the most commonly prescribed drugs that contain the penicillin family, with up to 10 percent of people reporting an allergy.

20 Oct 2016

FDA approves new therapy for initial treatment of soft tissue sarcoma

The U.S. Food and Drug Administration today granted accelerated approval to Lartruvo (olaratumab) with doxorubicin to treat adults with certain types of soft tissue sarcoma (STS), which are cancers that develop in muscles, fat, tendons or other soft tissues.

19 Oct 2016

Johns Hopkins wins $16 million contract to find ways to optimize antibiotic prescribing

Superbugs are causing a super problem in health care, but combating these drug-resistant bacteria presents quite a challenge.

19 Oct 2016

BetterYou’s oral spray effective in correcting vitamin D insufficiency in athletes, study shows

The findings of a study by Ulster University in conjunction with health pioneers BetterYou, have confirmed existing literature showing how athletes, despite spending an above average amount of time outdoors, are still at risk of vitamin D deficiency.

From BetterYou Ltd 19 Oct 2016

NPS MedicineWise encourages health professionals to participate in Antibiotic Awareness Week 2016

NPS MedicineWise is encouraging health professionals and community groups to get involved in the upcoming Antibiotic Awareness Week 2016.

19 Oct 2016

Domain Therapeutics and Medicxi partner to launch Mavalon Therapeutics

Domain Therapeutics, a biopharmaceutical company that specializes in the discovery and development of G protein-coupled receptor (GPCR) drugs, today announces the creation of Mavalon Therapeutics, a company focused on stopping the progression of Parkinson’s disease.

19 Oct 2016

Novel toothpaste produces significant reductions in dental plaque and inflammation

For decades, research has suggested a link between oral health and inflammatory diseases affecting the entire body -- in particular, heart attacks and strokes.

19 Oct 2016

Folinic acid treatment could help improve language and communication skills of children with ASD

Prescription doses of folinic acid, which is a reduced form of a B vitamin known as folate, could help improve the language and communication skills of children with autism spectrum disorder (ASD).

18 Oct 2016

Study identifies factors that may contribute to use of PIMs at the end of life

A recent interview study has uncovered factors that may contribute to the use of potentially inappropriate medications (PIMs) at the end of life.

18 Oct 2016

EKF Diagnostics’ novel diabetic biomarker test successfully externally verified

EKF, announces that its Glycated Serum Protein LiquiColor diabetic biomarker test has been verified for use on the Siemens Vista chemistry analyzer.

From EKF Diagnostics 18 Oct 2016

Porvair announce record sales of microplate evaporators

Porvair Sciences has confirmed that 2016 will see record sales of its Ultravap and Minivap ranges of blowdown evaporators to laboratories worldwide. The company first began selling nitrogen blowdown evaporators for microplate sample drying in 1999.

From Porvair Sciences Limited 18 Oct 2016

Anti-inflammatory drugs may improve severity of depressive symptoms, study finds

Anti-inflammatory drugs similar to those used to treat conditions such as rheumatoid arthritis and psoriasis could in future be used to treat some cases of depression, concludes a review led by the University of Cambridge, which further implicates our immune system in mental health disorders.

18 Oct 2016

Cold medication could suppress spread of bladder cancers

Hokkaido University researchers have discovered that a nonsteroid anti-inflammatory drug used for treating colds suppresses the spread of bladder cancers and reduces their chemoresistance in mice, raising hopes of a future cure for advanced bladder cancers.

17 Oct 2016

Moderate calcium intake not linked to coronary artery calcification, says UAB cardiologist

A study recently published in the Journal of the American Heart Association is prompting headlines like "Calcium supplements might hurt your heart."

17 Oct 2016

Cambridge Cognition announces new contracts for CANTAB Connect for HAL testing of investigational drugs

Cambridge Cognition today announced a series of new contracts for its cloud-based CANTAB Connect software platform for the Human Abuse Liability (HAL) testing of investigational drugs.

17 Oct 2016

Study quantifies burden of adverse drug reactions in general adult population

In a study of 1000 adult patients with unplanned admission to a tertiary hospital in Singapore, the prevalence of adverse drug reactions (ADRs) at the time of admission was 12.4 percent, and the prevalence of ADRs causing admission to the hospital was 8.1 percent.

17 Oct 2016

New stem cell-based strategy may help predict heart-damaging effects of drugs

Coaxing stem cells from patients to become heart cells may help clinicians personalize drug treatments and prevent heart-related toxicity.

17 Oct 2016

Scientists develop software package to predict chemical properties of molecules

Scientists from MIPT's Research Center for Molecular Mechanisms of Aging and Age-Related Diseases together with Inria research center, Grenoble, France have developed a software package called Knodle to determine an atom's hybridization, bond orders and functional groups' annotation in molecules.

17 Oct 2016

Wayne State receives NIH grant to study use of opioid addiction drug to fight relapse in recovering addicts

A team led by Wayne State University School of Medicine researcher Mark Greenwald, Ph.D., will use a four-year, $2,279,723 competitively renewed grant from the National Institute on Drug Abuse of the National Institutes of Health to explore whether the opioid addiction treatment medication buprenorphine can decrease the magnitude and/or duration of responses to stressors faced by recovering addicts.

15 Oct 2016

Scientists at NIH and Emory University induce sustained remission in SIV-infected monkeys

Scientists at the National Institutes of Health and Emory University have experimentally induced sustained remission of SIV, the simian form of HIV, in infected monkeys.

14 Oct 2016

Pharmaceutical News

New bio-photonic device aims to take drug hypersensitivity detection into new era

FDA approves new therapy for initial treatment of soft tissue sarcoma

Johns Hopkins wins $16 million contract to find ways to optimize antibiotic prescribing

BetterYou’s oral spray effective in correcting vitamin D insufficiency in athletes, study shows

NPS MedicineWise encourages health professionals to participate in Antibiotic Awareness Week 2016

Domain Therapeutics and Medicxi partner to launch Mavalon Therapeutics

Novel toothpaste produces significant reductions in dental plaque and inflammation

Folinic acid treatment could help improve language and communication skills of children with ASD

Study identifies factors that may contribute to use of PIMs at the end of life

EKF Diagnostics’ novel diabetic biomarker test successfully externally verified

Porvair announce record sales of microplate evaporators

Anti-inflammatory drugs may improve severity of depressive symptoms, study finds

Cold medication could suppress spread of bladder cancers

Moderate calcium intake not linked to coronary artery calcification, says UAB cardiologist

Cambridge Cognition announces new contracts for CANTAB Connect for HAL testing of investigational drugs

Study quantifies burden of adverse drug reactions in general adult population

New stem cell-based strategy may help predict heart-damaging effects of drugs

Scientists develop software package to predict chemical properties of molecules

Wayne State receives NIH grant to study use of opioid addiction drug to fight relapse in recovering addicts

Scientists at NIH and Emory University induce sustained remission in SIV-infected monkeys

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Latest News